Endothelial cell dysfunction, medial arterial calcification and osteoprotegerin in diabetes

British Journal of Diabetes and Vascular Disease

Volumn 10, Issue 2, 2010, Pages 71-77

  Singh, Dhruv K ^a,b   Winocour, Peter ^a   Farrington, Ken ^b  

^a QUEEN ELIZABETH II HOSPITAL   (United Kingdom)

^b LISTER HOSPITAL   (United Kingdom)

Author keywords

Diabetic vasculopathy; Endothelial cell dysfunction; Medial arterial calcification; Osteoprotegerin; RANKL

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; INSULIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; OSTEOPROTEGERIN; PROTEIN KINASE B; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTERY CALCIFICATION; ATHEROSCLEROSIS; BONE MATRIX; DIABETES MELLITUS; ELASTIC FIBER; ELECTRON BEAM TOMOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOBLAST; OSTEOCLAST; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 77952493593     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/1474651409355453     Document Type: Review

References (71)

1. Morrish NJ, Wang SL, Stevens LK et al. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001;44(suppl 2):S14-21.
2. Most RS, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 1983;6:87-91.
3. Soedamah-Muthu SS, Chaturvedi N, Toeller M et al. Risk Factors for Coronary Heart Disease in Type 1 Diabetic Patients in Europe: The EURODIAB Prospective Complications Study. Diabetes Care 2004;27:530-537 (Pubitemid 38174083)
4. Stern MP. Diabetes and cardiovascular disease. The 'common soil' hypothesis. Diabetes 1995;44:369-374
5. Nicolaides E, Jones CJ. Review. Type 2 diabetes: implications for macrovascular mechanics and disease. Br J Diabetes Vasc Dis 2002;2:9-12.
6. Lehto S, Niskanen L, Suhonen M et al. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996;16:978-983
7. Lomashvili KA, Khawandi W, O'Neill WC. Reduced plasma pyrophosphate levels in hemodialysis patients. J Am Soc Nephrol 2005;16: 2495-2500
8. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) 2005;109:143-159
9. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995;95:2266-2274
10. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest 1992;90:456-461
11. Fleming I, Busse R. NO: the primary EDRF. J Mol Cell Cardiol 1999;31:5-14.
12. Schiffrin EL. A critical review of the role of endothelial factors in the pathogenesis of hypertension. J Cardiovasc Pharmacol 2001;38 (suppl 2):S3-6.
13. Hwang SJ, Ballantyne CM, Sharrett AR et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 1997;96:4219-4225
14. Miyamoto K, Ogura Y, Kenmochi S, Honda Y. Role of leukocytes in diabetic microcirculatory disturbances. Microvasc Res 1997;54:43-48
15. Colwell JA, Nesto RW. The platelet in diabetes: focus on prevention of ischemic events. Diabetes Care 2003;26:2181-2188
16. Ding H, Triggle CR. Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium. Vasc Health Risk Manag 2005;1:55-71.
17. Rudic RD, Sessa WC. Nitric oxide in endothelial dysfunction and vascular remodeling: clinical correlates and experimental links. Am J Hum Genet 1999;64:673-677
18. Corretti MC, Anderson TJ, Benjamin EJ et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-265
19. Vincent MA, Barrett EJ, Lindner JR et al. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab 2003;285:E123-9.
20. Vervoort G, Lutterman JA, Smits P et al. Transcapillary escape rate of albumin is increased and related to haemodynamic changes in normo-albuminuric type 1 diabetic patients. J Hypertens 1999;17(12 Pt 2):1911-1916
21. Bassenge E, Zanzinger J. Nitrates in different vascular beds, nitrate tolerance, and interactions with endothelial function. Am J Cardiol 1992;70:23B-9B.
22. Maiello M, Boeri D, Podesta F et al. Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes 1992;41:1009-1015
23. Spranger J, Kroke A, Mohlig M et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003;52:812-817
24. Pradhan AD, Manson JE, Rifai N et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001 ;286:327-334
25. Shachor-Meyouhas Y, Pillar G, Shehadeh N. Uncontrolled type 1 diabetes mellitus and endothelial dysfunction in adolescents. Isr Med Assoc J 2007;9:637-640
26. Kanters SD, Algra A, Banga JD. Carotid intima-media thickness in hyperlipidemic type I and type II diabetic patients. Diabetes Care 1997;20:276-280
27. Stehouwer CD, Fischer HR, van Kuijk AW, Polak BC, Donker AJ. Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes 1995;44:561-564
28. Naidoo DP. The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes. Cardiovasc J S Afr 2002;13:194-199
29. Stehouwer C, Yudkin J, Fioretto P, Nosadini R. How heterogeneous is microalbuminuria in diabetes mellitus? The case for 'benign' and 'malignant' microalbuminuria. Nephrol Dial Transplant 1998;13:2751-2754
30. Yamagishi S, Nakamura K, Jinnouchi Y et al. Molecular mechanisms for vascular injury in the metabolic syndrome. Drugs Exp Clin Res 2005;31:123-129 (Pubitemid 40942954)
31. Caballero AE, Arora S, Saouaf R etal. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 1999;48:1856-1862
32. Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004;291:1978-1986
33. Wolpert HA, Steen SN, Istfan NW, Simonson DC. Insulin modulates circulating endothelin-1 levels in humans. Metabolism 1993;42:1027-1030
34. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin- mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994;94:1172-1179
35. Zeng G, Nystrom FH, Ravichandran LV et al. Roles for Insulin Receptor, PI3-Kinase, and Akt in Insulin-Signaling Pathways Related to Production of Nitric Oxide in Human Vascular Endothelial Cells. Circulation 2000;101:1539-1545
36. Vicent D, Ilany J, Kondo T et al. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest 2003;111:1373-1380
37. Hermann C, Assmus B, Urbich C et al. Insulin-Mediated Stimulation of Protein Kinase Akt: A Potent Survival Signaling Cascade for Endothelial Cells. Arterioscler Thromb Vasc Biol 2000;20:402-409
38. Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev 2006;22:423-436
39. Steinberg HO, Baron AD. Vascular function, insulin resistance and fatty acids. Diabetologia 2002;45:623-634
40. McMillan DE. Disturbance of serum viscosity in diabetes mellitus. J Clin Invest 1974;53:1071-1079
41. Cagliero E, Maiello M, Boeri D, Roy S, Lorenzi M. Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest 1988 Aug;82:735-738
42. Graier WF, Grubenthal I, Dittrich P et al. Intracellular mechanism of high D-glucose-induced modulation of vascular cell proliferation. Eur J Pharmacol 1995;294:221-229
43. McMillan DE. Increased levels of acute-phase serum proteins in diabetes. Metabolism 1989;38:1042-1046
44. Baumgartner-Parzer SM, Wagner L, Pettermann M et al. Modulation by high glucose of adhesion molecule expression in cultured endothelial cells. Diabetologia 1995;38:1367-1370
45. Baumgartner-Parzer SM, Wagner L, Pettermann M et al. High-glucose- triggered apoptosis in cultured endothelial cells. Diabetes 1995;44:1323-1327
46. Lum H, Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 2001;280:C719-41.
47. Ritthaler U, Deng Y, Zhang Y et al. Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am J Pathol 1995;146:688-694
48. O'Driscoll G, Green D, Maiorana et al. Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1999;33:1506-1511
49. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 2004;286: E686-96.
50. Nicholls SJ, Tuzcu EM, Kalidindi S et al. Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. J Am Coll Cardiol 2008;52:255-262
51. Shanahan CM, Cary NRB, Salisbury JR et al. Medial localization of mineralization-regulating proteins in association with Monckebergæs sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999;100:2168-2176
52. Secchiero P, Corallini F, Pandolfi A et al. An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. Am J Pathol 2006;169:2236-2244
53. Schoppet M, Al-Fakhri N, Franke FE et al. Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Monckeberg's sclerosis and atherosclerosis. J Clin Endocrinol Metab 2004;89:4104-4112
54. Guzman RJ. Clinical, cellular, and molecular aspects of arterial calcification. J Vasc Surg 2007;45(suppl A):A57-63.
55. Chen PL, Easton A. Apoptotic phenotype alters the capacity of tumor necrosis factor-related apoptosis-inducing ligand to induce human vascular endothelial activation. J Vasc Res 2008;45:11 1-22.
56. Collin-Osdoby P, Rothe L, Anderson F et al. Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J Biol Chem 2001;276:20659-20672
57. Hayden MR, Tyagi SC, Kolb L et al. Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. Cardiovasc Diabetol 2005;4:4.
58. Csiszar A, Smith KE, Koller A et al. Regulation of bone morphogenetic protein-2 expression in endothelial cells: role of nuclear factor-kappaB activation by tumor necrosis factor-alpha, H2O2, and high intravascular pressure. Circulation 2005;111:2364-2372
59. Shao JS, Cai J, Towler DA. Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol 2006;26:1423-1430
60. Al-Aly Z, Shao JS, Lai CF et al. Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice. Arterioscler Thromb Vasc Biol 2007;27:2589-2596
61. Sugitani H, Wachi H, Mecham RP, Seyama Y. Accelerated calcification represses the expression of elastic fiber components and lysyl oxidase in cultured bovine aortic smooth muscle cells. J Atheroscler Thromb 2002;9:292-298
62. Trion A, van der LA. Vascular smooth muscle cells and calcification in atherosclerosis. Am Heart J 2004;147:808-814
63. Johnson K, Polewski M, van Etten D, Terkeltaub R. Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1 -/- mice. Arterioscler Thromb Vasc Biol 2005;25:686-691
64. Demetriou M, Binkert C, Sukhu B et al. Fetuin/alpha 2-HS glycoprotein is a transforming growth factor-beta type ii receptor mimic and cytokine antagonist. J Biol Chem 1996;271:12755-12761
65. Watson KE, Bostrom K, Ravindranath R et al. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 1994;93:2106-2113
66. Schoppet M, Preissner KT, Hofbauer LC. RANK ligand and osteoprote-gerin: paracrine regulators of bone metabolism and vascular function. Arterioscler Thromb Vasc Biol 2002;22:549-553
67. Malyankar UM, Scatena M, Suchland KL et al. Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells. J Biol Chem 2000;275:20959-20962
68. Shin JY, Shin YG, Chung CH. Elevated serum osteoprotegerin levels are associated with vascular endothelial dysfunction in type 2 diabetes. Diabetes Care 2006;29:1664-1666
69. O'Rourke RA, Brundage BH, Froelicher VF et al. American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation 2000;102:126-140
70. Arad Y, Spadaro LA, Goodman K et al. Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow-up of 1173 asymptomatic subjects. Circulation 1996;93:1951-1953
71. Waugh N, Black C, Walker S et al. The effectiveness and cost-effectiveness of computed tomography screening for coronary artery disease: systematic review. Health Technol Assess 2006;10:iii-x,1.